Portola Pharmaceuticals Inc
Portola is a biotechnology company that develops and commercializes novel therapeutics for the treatment of thrombotic and hematologic disorders.
Business Model:
Revenue: $120.9M
Employees: 201-500
Industries / Tags:
Detailed Portola Pharmaceuticals Inc Information
Portola Pharmaceuticals Inc was acquired by
Alexion Pharmaceuticals.
The acquisition happend on 2020-05-05.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 270 E. Grand Avenue
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$259M
Raised Total:$772M
Social
Metrics
418,854Website Global Rank
129,780Website Monthly Traffic
Twitter Followers
Description
Portola is a biotechnology company that develops and commercializes novel therapeutics for the treatment of thrombotic and hematologic disorders.
Contact Phone:
+16502467000
Contact Email:
Portola Pharmaceuticals Inc went public on 5/23/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/23/2013
IPO Valuation:
$469M
Ticker Symbol:
PTLA
Amount Raised:
$100M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
